Assessing lung cancer progression and survival with infrared spectroscopy of blood serum
Identifying the combined capacity of infrared fingerprinting to complement primary lung cancer diagnostics and to assist in the assessment of lung cancer survival represents the first proof-of-concept study underscoring the potential of this profiling platform. This may provide new avenues for the development of tailored, personalized treatment decision-making.
Authors
- Kosmas V. Kepesidis (ORCID: https://orcid.org/0000-0002-6391-7743)
- Mihaela Žigman (ORCID: https://orcid.org/0000-0001-8306-1922)
- Frank Fleischmann
- Amanda Tufman (ORCID: https://orcid.org/0000-0001-9243-9050)
- Ina Koch (ORCID: https://orcid.org/0000-0002-8766-017X)
- Niels Reinmuth (ORCID: https://orcid.org/0000-0002-7369-4512)
- Mircea-Gabriel Stoleriu
- Jürgen Behr (ORCID: https://orcid.org/0000-0002-9151-4829)
- Nico Feiler
- Sabine Eiselen
- Lea Gigou (ORCID: https://orcid.org/0009-0006-8452-0346)
- Jacqueline Aschauer
Institutions
- Max Planck Institute of Quantum Optics (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- German Center for Lung Research (DE)
- Max Planck Computing and Data Facility (DE)
- University of Veterinary Medicine (HU)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s12916-025-03924-3
- Citations
- 9
- Primary Topic
- Spectroscopy Techniques in Biomedical and Chemical Research
- Type
- article
- Field-Weighted Citation Impact
- 14.71
Funders
- Ludwig-Maximilians-Universität München
- Deutsches Zentrum für Lungenforschung